vs

Side-by-side financial comparison of Turtle Beach Corp (TBCH) and Zai Lab Ltd (ZLAB). Click either name above to swap in a different company.

Zai Lab Ltd is the larger business by last-quarter revenue ($127.1M vs $95.1M, roughly 1.3× Turtle Beach Corp). On growth, Zai Lab Ltd posted the faster year-over-year revenue change (17.1% vs -34.9%). Turtle Beach Corp produced more free cash flow last quarter ($13.1M vs $-26.7M). Over the past eight quarters, Turtle Beach Corp's revenue compounded faster (30.5% CAGR vs 20.8%).

The Turtle Beach Corporation is an American gaming accessory manufacturer based in San Diego, California. The company has roots dating back to the 1970s where it developed sound cards, MIDI synthesizers, and various audio software packages and network audio devices. The company began making gaming headsets in 2005.

Zai Lab Ltd is a global biopharmaceutical company focused on developing, manufacturing and commercializing innovative therapies for oncology, autoimmune disorders, infectious diseases and other unmet medical needs. It operates primarily in the Greater China region and partners with leading global biotech firms to expand access to life-saving treatments for underserved patient populations.

TBCH vs ZLAB — Head-to-Head

Bigger by revenue
ZLAB
ZLAB
1.3× larger
ZLAB
$127.1M
$95.1M
TBCH
Growing faster (revenue YoY)
ZLAB
ZLAB
+52.0% gap
ZLAB
17.1%
-34.9%
TBCH
More free cash flow
TBCH
TBCH
$39.8M more FCF
TBCH
$13.1M
$-26.7M
ZLAB
Faster 2-yr revenue CAGR
TBCH
TBCH
Annualised
TBCH
30.5%
20.8%
ZLAB

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
TBCH
TBCH
ZLAB
ZLAB
Revenue
$95.1M
$127.1M
Net Profit
$17.6M
Gross Margin
50.0%
51.0%
Operating Margin
22.0%
-54.6%
Net Margin
18.5%
Revenue YoY
-34.9%
17.1%
Net Profit YoY
-12.6%
EPS (diluted)
$0.86
$-0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
TBCH
TBCH
ZLAB
ZLAB
Q4 25
$95.1M
$127.1M
Q3 25
$80.5M
$115.4M
Q2 25
$80.5M
$109.1M
Q1 25
$63.9M
$105.7M
Q4 24
$146.1M
$108.5M
Q3 24
$94.4M
$101.8M
Q2 24
$76.5M
$100.1M
Q1 24
$55.8M
$87.1M
Net Profit
TBCH
TBCH
ZLAB
ZLAB
Q4 25
$17.6M
Q3 25
$1.7M
$-36.0M
Q2 25
$-2.9M
$-40.7M
Q1 25
$-664.0K
$-48.4M
Q4 24
$20.1M
Q3 24
$3.4M
$-41.7M
Q2 24
$-7.5M
$-80.3M
Q1 24
$155.0K
$-53.5M
Gross Margin
TBCH
TBCH
ZLAB
ZLAB
Q4 25
50.0%
51.0%
Q3 25
37.4%
59.5%
Q2 25
22.7%
60.6%
Q1 25
36.6%
63.6%
Q4 24
37.0%
61.5%
Q3 24
36.2%
64.1%
Q2 24
30.2%
64.9%
Q1 24
31.8%
61.4%
Operating Margin
TBCH
TBCH
ZLAB
ZLAB
Q4 25
22.0%
-54.6%
Q3 25
6.7%
-42.3%
Q2 25
-0.4%
-50.3%
Q1 25
2.4%
-53.3%
Q4 24
16.0%
-62.6%
Q3 24
6.8%
-66.6%
Q2 24
-5.4%
-76.0%
Q1 24
-10.2%
-80.7%
Net Margin
TBCH
TBCH
ZLAB
ZLAB
Q4 25
18.5%
Q3 25
2.1%
-31.2%
Q2 25
-3.6%
-37.3%
Q1 25
-1.0%
-45.8%
Q4 24
13.8%
Q3 24
3.6%
-40.9%
Q2 24
-9.8%
-80.2%
Q1 24
0.3%
-61.4%
EPS (diluted)
TBCH
TBCH
ZLAB
ZLAB
Q4 25
$0.86
$-0.05
Q3 25
$0.08
$-0.03
Q2 25
$-0.14
$-0.04
Q1 25
$-0.03
$-0.04
Q4 24
$0.96
$-0.09
Q3 24
$0.16
$-0.04
Q2 24
$-0.35
$-0.08
Q1 24
$0.01
$-0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
TBCH
TBCH
ZLAB
ZLAB
Cash + ST InvestmentsLiquidity on hand
$17.0M
$689.6M
Total DebtLower is stronger
$55.7M
Stockholders' EquityBook value
$128.5M
$715.5M
Total Assets
$269.1M
$1.2B
Debt / EquityLower = less leverage
0.43×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
TBCH
TBCH
ZLAB
ZLAB
Q4 25
$17.0M
$689.6M
Q3 25
$12.3M
$717.2M
Q2 25
$11.7M
$732.2M
Q1 25
$11.7M
$757.3M
Q4 24
$13.0M
$779.7M
Q3 24
$13.8M
$616.1M
Q2 24
$12.5M
$630.0M
Q1 24
$17.8M
$650.8M
Total Debt
TBCH
TBCH
ZLAB
ZLAB
Q4 25
$55.7M
Q3 25
$57.9M
Q2 25
$43.3M
Q1 25
$48.6M
Q4 24
$49.0M
Q3 24
$49.3M
Q2 24
$49.6M
Q1 24
$49.9M
Stockholders' Equity
TBCH
TBCH
ZLAB
ZLAB
Q4 25
$128.5M
$715.5M
Q3 25
$110.7M
$759.9M
Q2 25
$116.8M
$791.7M
Q1 25
$120.9M
$810.8M
Q4 24
$120.6M
$840.9M
Q3 24
$101.8M
$667.7M
Q2 24
$105.3M
$704.2M
Q1 24
$125.2M
$762.2M
Total Assets
TBCH
TBCH
ZLAB
ZLAB
Q4 25
$269.1M
$1.2B
Q3 25
$278.2M
$1.2B
Q2 25
$240.2M
$1.2B
Q1 25
$247.0M
$1.2B
Q4 24
$298.9M
$1.2B
Q3 24
$313.2M
$985.3M
Q2 24
$264.4M
$987.4M
Q1 24
$258.4M
$988.4M
Debt / Equity
TBCH
TBCH
ZLAB
ZLAB
Q4 25
0.43×
Q3 25
0.52×
Q2 25
0.37×
Q1 25
0.40×
Q4 24
0.41×
Q3 24
0.48×
Q2 24
0.47×
Q1 24
0.40×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
TBCH
TBCH
ZLAB
ZLAB
Operating Cash FlowLast quarter
$13.3M
$-26.0M
Free Cash FlowOCF − Capex
$13.1M
$-26.7M
FCF MarginFCF / Revenue
13.8%
-21.0%
Capex IntensityCapex / Revenue
0.3%
0.5%
Cash ConversionOCF / Net Profit
0.76×
TTM Free Cash FlowTrailing 4 quarters
$34.0M
$-158.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
TBCH
TBCH
ZLAB
ZLAB
Q4 25
$13.3M
$-26.0M
Q3 25
$-15.2M
$-32.0M
Q2 25
$-3.1M
$-31.0M
Q1 25
$40.5M
$-61.7M
Q4 24
$14.3M
$-55.8M
Q3 24
$-23.2M
$-26.8M
Q2 24
$-12.6M
$-42.2M
Q1 24
$27.3M
$-90.1M
Free Cash Flow
TBCH
TBCH
ZLAB
ZLAB
Q4 25
$13.1M
$-26.7M
Q3 25
$-15.9M
$-35.0M
Q2 25
$-3.5M
$-33.9M
Q1 25
$40.3M
$-63.2M
Q4 24
$12.8M
$-58.4M
Q3 24
$-24.6M
$-28.2M
Q2 24
$-13.9M
$-42.9M
Q1 24
$26.5M
$-91.1M
FCF Margin
TBCH
TBCH
ZLAB
ZLAB
Q4 25
13.8%
-21.0%
Q3 25
-19.7%
-30.4%
Q2 25
-4.3%
-31.1%
Q1 25
63.0%
-59.9%
Q4 24
8.8%
-53.8%
Q3 24
-26.1%
-27.7%
Q2 24
-18.1%
-42.9%
Q1 24
47.5%
-104.5%
Capex Intensity
TBCH
TBCH
ZLAB
ZLAB
Q4 25
0.3%
0.5%
Q3 25
0.8%
2.6%
Q2 25
0.4%
2.6%
Q1 25
0.3%
1.5%
Q4 24
1.0%
2.4%
Q3 24
1.5%
1.3%
Q2 24
1.6%
0.7%
Q1 24
1.3%
1.1%
Cash Conversion
TBCH
TBCH
ZLAB
ZLAB
Q4 25
0.76×
Q3 25
-8.84×
Q2 25
Q1 25
Q4 24
0.71×
Q3 24
-6.79×
Q2 24
Q1 24
175.85×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

TBCH
TBCH

Europe And Middle East$71.0M75%
Asia Pacific$13.3M14%
Other$10.8M11%

ZLAB
ZLAB

Zejula$56.0M44%
Other$21.9M17%
Nuzyra$16.0M13%
Optune$11.9M9%
XACDURO$10.7M8%
Qinlock$9.7M8%
AUGTYRO$836.0K1%

Related Comparisons